Glutathione S-transferase M1, T1, and P1 polymorphisms and ovarian cancer risk

A meta-analysis

Konstantinos P. Economopoulos, Theodoros N. Sergentanis, Nikos F. Vlahos

    Research output: Contribution to journalArticle

    Abstract

    Introduction: Cytosolic glutathione S-transferase (GST) comprises multiple isoenzymes that catalyze reactions between glutathione and lipophilic compounds with electrophilic centers, resulting in the neutralization of toxic compounds, xenobiotics, and products of oxidative stress. Several studies have examined whether GST polymorphisms (GSTM1 null/present genotype, GSTT1 null/present genotype, and GSTP1 Ile105Val) represent risk factors for ovarian cancer, as they all may denote reduced enzyme activity. This metaanalysis aimed to examine the associations between the aforementioned polymorphisms and ovarian cancer risk. Methods: The MEDLINE database was searched up to September 2009 using the appropriate terms. Case-control studies with no mutually overlapping populations were selected. Pooled odds ratios (ORs) were appropriately derived from fixed-effects or randomeffects models. Meta-regression with publication year was also performed. Results: Eight studies regarding GSTM1 null polymorphism status (2357 cases and 3044 controls), 6 studies concerning GSTT1 null polymorphism (1923 cases and 2759 controls), and 3 studies on GSTP1 Ile105Val were included in the meta-analysis. The GSTM1 null genotype was not associated with an increased risk for ovarian cancer (pooled OR, 1.031; 95% confidence interval, 0.867Y1.226; random effects). The GSTT1 null genotype was not associated with an increased ovarian cancer risk (pooled OR, 0.934; 95% confidence interval, 0.804Y1.086; random effects); similarly, no significant associations were demonstrated for GSTP1 Ile105Val. Conclusions: The examined GSTM1, GSTT1, and GSTP1 genotype polymorphisms do not seem to confer any additional risk for ovarian cancer. Given that the studies included in this meta-analysis involve mainly white populations, these results cannot be extrapolated on other populations, and additional data are needed for future race-specific analyses.

    Original languageEnglish (US)
    Pages (from-to)732-737
    Number of pages6
    JournalInternational Journal of Gynecological Cancer
    Volume20
    Issue number5
    DOIs
    StatePublished - Jul 2010

    Fingerprint

    Ovarian Neoplasms
    Meta-Analysis
    Genotype
    Odds Ratio
    Glutathione Transferase
    Confidence Intervals
    Population
    Poisons
    Xenobiotics
    MEDLINE
    Isoenzymes
    Glutathione
    Publications
    Case-Control Studies
    Oxidative Stress
    glutathione S-transferase T1
    glutathione S-transferase M1
    Databases
    Enzymes

    Keywords

    • GSTM1
    • GSTP1 polymorphism
    • GSTT1
    • Meta-analysis
    • Ovarian cancer
    • Ovarian tumors

    ASJC Scopus subject areas

    • Obstetrics and Gynecology
    • Oncology

    Cite this

    Glutathione S-transferase M1, T1, and P1 polymorphisms and ovarian cancer risk : A meta-analysis. / Economopoulos, Konstantinos P.; Sergentanis, Theodoros N.; Vlahos, Nikos F.

    In: International Journal of Gynecological Cancer, Vol. 20, No. 5, 07.2010, p. 732-737.

    Research output: Contribution to journalArticle

    Economopoulos, Konstantinos P. ; Sergentanis, Theodoros N. ; Vlahos, Nikos F. / Glutathione S-transferase M1, T1, and P1 polymorphisms and ovarian cancer risk : A meta-analysis. In: International Journal of Gynecological Cancer. 2010 ; Vol. 20, No. 5. pp. 732-737.
    @article{3cc9cb2f18c64530813327359f86998e,
    title = "Glutathione S-transferase M1, T1, and P1 polymorphisms and ovarian cancer risk: A meta-analysis",
    abstract = "Introduction: Cytosolic glutathione S-transferase (GST) comprises multiple isoenzymes that catalyze reactions between glutathione and lipophilic compounds with electrophilic centers, resulting in the neutralization of toxic compounds, xenobiotics, and products of oxidative stress. Several studies have examined whether GST polymorphisms (GSTM1 null/present genotype, GSTT1 null/present genotype, and GSTP1 Ile105Val) represent risk factors for ovarian cancer, as they all may denote reduced enzyme activity. This metaanalysis aimed to examine the associations between the aforementioned polymorphisms and ovarian cancer risk. Methods: The MEDLINE database was searched up to September 2009 using the appropriate terms. Case-control studies with no mutually overlapping populations were selected. Pooled odds ratios (ORs) were appropriately derived from fixed-effects or randomeffects models. Meta-regression with publication year was also performed. Results: Eight studies regarding GSTM1 null polymorphism status (2357 cases and 3044 controls), 6 studies concerning GSTT1 null polymorphism (1923 cases and 2759 controls), and 3 studies on GSTP1 Ile105Val were included in the meta-analysis. The GSTM1 null genotype was not associated with an increased risk for ovarian cancer (pooled OR, 1.031; 95{\%} confidence interval, 0.867Y1.226; random effects). The GSTT1 null genotype was not associated with an increased ovarian cancer risk (pooled OR, 0.934; 95{\%} confidence interval, 0.804Y1.086; random effects); similarly, no significant associations were demonstrated for GSTP1 Ile105Val. Conclusions: The examined GSTM1, GSTT1, and GSTP1 genotype polymorphisms do not seem to confer any additional risk for ovarian cancer. Given that the studies included in this meta-analysis involve mainly white populations, these results cannot be extrapolated on other populations, and additional data are needed for future race-specific analyses.",
    keywords = "GSTM1, GSTP1 polymorphism, GSTT1, Meta-analysis, Ovarian cancer, Ovarian tumors",
    author = "Economopoulos, {Konstantinos P.} and Sergentanis, {Theodoros N.} and Vlahos, {Nikos F.}",
    year = "2010",
    month = "7",
    doi = "10.1111/IGC.0b013e3181dedeb5",
    language = "English (US)",
    volume = "20",
    pages = "732--737",
    journal = "International Journal of Gynecological Cancer",
    issn = "1048-891X",
    publisher = "Lippincott Williams and Wilkins",
    number = "5",

    }

    TY - JOUR

    T1 - Glutathione S-transferase M1, T1, and P1 polymorphisms and ovarian cancer risk

    T2 - A meta-analysis

    AU - Economopoulos, Konstantinos P.

    AU - Sergentanis, Theodoros N.

    AU - Vlahos, Nikos F.

    PY - 2010/7

    Y1 - 2010/7

    N2 - Introduction: Cytosolic glutathione S-transferase (GST) comprises multiple isoenzymes that catalyze reactions between glutathione and lipophilic compounds with electrophilic centers, resulting in the neutralization of toxic compounds, xenobiotics, and products of oxidative stress. Several studies have examined whether GST polymorphisms (GSTM1 null/present genotype, GSTT1 null/present genotype, and GSTP1 Ile105Val) represent risk factors for ovarian cancer, as they all may denote reduced enzyme activity. This metaanalysis aimed to examine the associations between the aforementioned polymorphisms and ovarian cancer risk. Methods: The MEDLINE database was searched up to September 2009 using the appropriate terms. Case-control studies with no mutually overlapping populations were selected. Pooled odds ratios (ORs) were appropriately derived from fixed-effects or randomeffects models. Meta-regression with publication year was also performed. Results: Eight studies regarding GSTM1 null polymorphism status (2357 cases and 3044 controls), 6 studies concerning GSTT1 null polymorphism (1923 cases and 2759 controls), and 3 studies on GSTP1 Ile105Val were included in the meta-analysis. The GSTM1 null genotype was not associated with an increased risk for ovarian cancer (pooled OR, 1.031; 95% confidence interval, 0.867Y1.226; random effects). The GSTT1 null genotype was not associated with an increased ovarian cancer risk (pooled OR, 0.934; 95% confidence interval, 0.804Y1.086; random effects); similarly, no significant associations were demonstrated for GSTP1 Ile105Val. Conclusions: The examined GSTM1, GSTT1, and GSTP1 genotype polymorphisms do not seem to confer any additional risk for ovarian cancer. Given that the studies included in this meta-analysis involve mainly white populations, these results cannot be extrapolated on other populations, and additional data are needed for future race-specific analyses.

    AB - Introduction: Cytosolic glutathione S-transferase (GST) comprises multiple isoenzymes that catalyze reactions between glutathione and lipophilic compounds with electrophilic centers, resulting in the neutralization of toxic compounds, xenobiotics, and products of oxidative stress. Several studies have examined whether GST polymorphisms (GSTM1 null/present genotype, GSTT1 null/present genotype, and GSTP1 Ile105Val) represent risk factors for ovarian cancer, as they all may denote reduced enzyme activity. This metaanalysis aimed to examine the associations between the aforementioned polymorphisms and ovarian cancer risk. Methods: The MEDLINE database was searched up to September 2009 using the appropriate terms. Case-control studies with no mutually overlapping populations were selected. Pooled odds ratios (ORs) were appropriately derived from fixed-effects or randomeffects models. Meta-regression with publication year was also performed. Results: Eight studies regarding GSTM1 null polymorphism status (2357 cases and 3044 controls), 6 studies concerning GSTT1 null polymorphism (1923 cases and 2759 controls), and 3 studies on GSTP1 Ile105Val were included in the meta-analysis. The GSTM1 null genotype was not associated with an increased risk for ovarian cancer (pooled OR, 1.031; 95% confidence interval, 0.867Y1.226; random effects). The GSTT1 null genotype was not associated with an increased ovarian cancer risk (pooled OR, 0.934; 95% confidence interval, 0.804Y1.086; random effects); similarly, no significant associations were demonstrated for GSTP1 Ile105Val. Conclusions: The examined GSTM1, GSTT1, and GSTP1 genotype polymorphisms do not seem to confer any additional risk for ovarian cancer. Given that the studies included in this meta-analysis involve mainly white populations, these results cannot be extrapolated on other populations, and additional data are needed for future race-specific analyses.

    KW - GSTM1

    KW - GSTP1 polymorphism

    KW - GSTT1

    KW - Meta-analysis

    KW - Ovarian cancer

    KW - Ovarian tumors

    UR - http://www.scopus.com/inward/record.url?scp=77956816039&partnerID=8YFLogxK

    UR - http://www.scopus.com/inward/citedby.url?scp=77956816039&partnerID=8YFLogxK

    U2 - 10.1111/IGC.0b013e3181dedeb5

    DO - 10.1111/IGC.0b013e3181dedeb5

    M3 - Article

    VL - 20

    SP - 732

    EP - 737

    JO - International Journal of Gynecological Cancer

    JF - International Journal of Gynecological Cancer

    SN - 1048-891X

    IS - 5

    ER -